Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma.
Otte
Andreas
A
Thompson
Sally L
SL
D003362:Cost-Benefit Analysis; D006801:Humans; D007348:Insurance, Health; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D016499:Radioimmunotherapy / Q000191:economics* / Q000379:methods*; D012449:Safety; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
D015021:Yttrium Radioisotopes